NIRAPARIB vs NIROGACESTAT HYDROBROMIDE: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
NIRAPARIB vs NIROGACESTAT HYDROBROMIDE: Safety Overview
| Metric | NIRAPARIB | NIROGACESTAT HYDROBROMIDE |
|---|---|---|
| Total FAERS Reports | 21,634 | 166 |
| Deaths Reported | 1,370 | 0 |
| Death Rate | 6.3% | N/A |
| Hospitalizations | 4,892 | 18 |
| Average Patient Age | 65.7 yrs | 46.8 yrs |
| % Female Patients | 98.5% | 63.0% |
| FDA Approval Date | Apr 26, 2023 | Apr 4, 2024 |
| Manufacturer | GlaxoSmithKline LLC | N/A |
| Route | ORAL | N/A |
| Marketing Status | Discontinued | Prescription |